A 33-kD glycoprotein, known as the "prostate-specific antigen," was purified to homogeneity from human seminal plasma. The prostatic protein was identified as a serine protease, and its NH2-terminal sequence strongly suggests that it belongs to the family of glandular kallikreins. The structural protein of human seminal coagulum, the predominant protein in seminal vesicle secretion, was rapidly cleaved by the prostatic enzyme, which suggests that this seminal vesicle protein may serve as the physiological substrate for the protease. The prostatic enzyme hydrolyzed arginine-and lysine-containing substrates with a distinct preference for the former. All synthetic substrates tested were poor substrates for the enzyme. Synthetic Factor XIa substrate (pyro-glutamyl-prolyl-arginine-p-nitroanilide), and the synthetic kallikrein substrate (H-D-prolyl-phenylalanyl-arginine-p-nitroanilide) were hydrolyzed with maximum specific activities at 23 degrees C of 79 and 34 nmol/min per mg and Km values of 1.0 and 0.45 mM, respectively. Synthetic substrates for plasmin, chymotrypsin, and elastase were either not hydrolyzed by the enzyme at all, or only hydrolyzed very slowly.
Introduction
A seminal coagulum forms immediately after the ejaculation of human semen. The predominant protein in seminal vesicle secretion constitutes the structural protein of the clot (1) . This protein, known as the high molecular weight seminal vesicle protein (HMW-SV-protein),' forms disulfide-linked high molecular weight complexes but gives major protein bands ofsome 52, 71, and 76 kD on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in the presence of reducing agents (2, 3) . The HMW-SV-protein is cleaved by proteases in the prostatic fluid to several low molecular weight proteins in concurrence with the liquefaction of the clot (1, 3) . A predominant cleavage product of the HMW-SV-protein is a 5.8-kD basic protein that in its NH2-terminal portion is similar to the histidine-rich region of bovine high molecular weight kininogen (4) (5) (6) . In the rat, the NH2-terminal portion of this basic protein is also reported to inhibit the secretion of pituitary follicle stimulating hormone (7) .
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1. Abbreviations used in this paper: Con A, concanavalin A; DFP, diisopropylfluorophosphate; DTT, dithiothreitol; HMW-SV-protein, high molecular weight seminal vesicle protein; NPGB, 4-nitrophenyl-guanidobenzoate; pNA, 4-nitroanilide; SDS-PAGE, sodium dodecyl sulfatepolyacrylamide gel electrophoresis.
A 30-kD arginyl-cleaving serine protease is predominant in canine prostatic fluid (8, 9) . Sequence homologies with glandular kallikreins strongly suggest that the canine protease is a member ofthe kallikrein family (10) . A secretory protein from the human prostate, known as "prostate-specific antigen," has recently been shown to be a proteolytic enzyme (I 1). This 33-kD glycoprotein is present in human prostatic fluid in high concentration (12) . Comparison of the reported NH2-terminal sequences of the human prostatic antigen (I 1) and of the canine protease (10) (S 2366 ), H-o-prolyl-phenylalanyl-argininepNA (S 2302), H-D-valyl-leucyl-arginine-pNA (S 2266), H-o-phenylalanyl-pipecolyl-arginine-pNA (S2238), and H-D-valyl-leucyl-lysine-pNA (S 2251) from Kabi (Stockholm, Sweden); No-benzoyl-arginine-pNA from British Drug Houses (Poole, United Kingdom); and succinyl-(alanine)3-pNA from the Protein Research Foundation (Minoh, Osaka, Japan); carboxymethyl-Sepharose, DEAE-Sepharose, and concanavalin A (Con A)-Sepharose from Pharmacia (Uppsala, Sweden); and Ultrogel Aca 54 from LKB (Bromma, Sweden).
Materials. Human semen and pure prostatic fluid were obtained as previously described (13) . Pure seminal vesicle secretion was aspirated from the vesicular ducts during an operation of a male patient for carcinoma in the urinary bladder (3). Coagulated semen was collected in vessels containing 0.5 ml of 0.5 M O-phenanthroline that were placed in ice-cold H20 directly after ejaculation and then frozen at -70°C until required (1). The coagulated semen was washed free of soluble components and the washed clots were dissolved, reduced, and carboxymethylated as previously described (3) . Carboxymethylated clots were extensively dialyzed against 50 mM Tris-HCl with 0.5 M NaCl, pH 8.0.
Electrophoretic techniques. Agarose gel electrophoresis was performed according to standard procedures (14) . SDS-PAGE in a 9-17% polyacrylamide gel gradient was performed according to Blobel and Dobberstein (15) . Gels with radioactive proteins were dried after protein fixation and treatment with EN3 HANCE according to the manufacturer's instructions, and then exposed for 30 d to x-ray films at -70'C before development. Throughout the purification procedures the individual fractions were analyzed with electroimmunoassay using a polyclonal rabbit antiserum raised against the purified prostatic 33-kD glycoprotein. The electroimmunoassay was run at 60 V for 16 h in gels that contained 1% of antiserum.
Protein purification. The 33-kD prostatic glycoprotein was purified from 50 ml of pooled seminal plasma. The seminal plasma pool wasAll buffers used were made up to 10 mM with benzamidine. The seminal plasma pool was applied to a carboxymethyl-Sepharose column (40 X 2.5 cm) equilibrated with 50 mM Tris-HCl, pH 7.5. The prostatic glycoprotein passed through the column with the equilibrating buffer. Fractions containing the protein were pooled and concentrated to -100 ml. This pool was applied to a DEAE-Sepharose column (30 X 2.5 cm) equilibrated with 30 mM sodium phosphate, pH 6.4. The prostatic glycoprotein passed through the column with the equilibrating buffer and the fractions were pooled and concentrated. The pool was subsequently applied to a Con A-Sepharose column (16 X 2.5 cm) equilibrated with 50 mM Tris also containing 0.5 M NaCl, pH 7.5. The prostatic glycoprotein was eluted from the column with 0.2 M a-methyl-mannoside added to the equilibrating buffer and the fractions were pooled and concentrated ( Fig. 1 A) . The protein pool was applied to an Ultrogel Aca 54 column (88 X 1.6 cm) equilibrated with 50 mM Tris and 0.5 M NaCa, pH 8.0 (Fig. 1 B) . Fractions reacting with the antibody were pooled and the resulting material found to contain a single band of -33 kD as judged by SDS-PAGE of reduced samples (Fig. 2 A) . The recovery after each purification step is given in Table I .
Enzyme assays. Hydrolysis ofthe tripeptide pNa-substrates and N*-benzoyl-arginine-pNA was measured with a UV 260 recording spectrophotometer (Shimadzu Seisakusho Ltd., Kyoto, Japan) at 405 nm. Hydrolysis of Na-benzoyl-L-tyrosine ethyl ester was measured at 253 nm. All incubations were performed at 23'+2'C in 50 mM Tris, pH 7.8. The reaction was initiated by the addition of the purified protein to I ml ofsubstrate solution, while the absorbance was monitored for at least 20 min against a blank containing the substrate solution.
Labeling with [3HJDFP. Samples of purified protein (each containing -4 Mgg), pure prostatic fluid (4 Ml), and seminal plasma (4 Ml) were incubated with 3 Ml of [3H]DFP (5 mCi/ml) in 15 Ml of 50 mM Tris-HC1, pH 7.8, for 10-30 min at room temperature. The samples were subsequently analyzed using SDS-PAGE after reduction and carboxymethylation.
Titration ofenzymatic activity. Active site titration with NPGB was performed according to Chase and Shaw (17) . The molar concentration ofthe purified protein was calculated from amino acid analysis assuming a mass of 33 kD and a carbohydrate content of 10% (12) .
Amino acid analysis and sequence determination. The purified protein was reduced for I h with 25 mM dithiothreitol (DTT) in 0.5 M Tris-HCI with 6 M guanidine-HCI, pH 8.0, and then carboxymethylated for 2 h with 50 mM iodoacetic acid in 0.5 M Tris, pH 8 (Fig. 2 B) . The incorporation of [3H]DFP was blocked if the purified protein had been treated with unlabeled DFP (10 mM), or ifit had been carboxymethylated before it was incubated with the radioactive compound. One single band, with the same mass as the purified protein, incorporated [3H]DFP both in pure prostatic secretion, and in seminal plasma as judged by SDS-PAGE (Fig. 2 B) .
Cleavage ofHMW-SV-protein by thepurified protein. Native HMW-SV-protein (in seminal vesicle secretion) and carboxymethylated HMW-SV-protein (from seminal clots) were analyzed by SDS-PAGE (Fig. 3) . The intact HMW-SV-protein gave three major bands of 52, 71, and 76 kD, as marked with arrows in the figure. The series of minor bands with molecular masses below 50 kD (lanes I and 6 in Fig. 3 Fig.  3 ). Below the weakly stained 7 l-kD band of HMW-SV-protein in lane 7 a faint 67-kD band of albumin is seen. Proteins with Na-benzoyl-arginine-pNA 7.5 All assays were performed at 23±+20C and pH 7. (Fig.  4) . The basic low molecular mass degradation products are HMW-SV-related proteins, as previously shown by immunoblotting (1, 3) . In addition, acidic cleavage products also appeared when seminal clots (Fig. 4) Fig. 3 ).
Discussion
The purified protein had a molecular mass of -33 kD and contained carbohydrate as judged by the high affinity for Con A.
Its NH2-terminal sequence was identical to that reported for prostate-specific antigen (1 1). These results, in conjunction with the prostatic origin of our purified protein, provide evidence of its identity with the prostate-specific antigen. Ban et al. (11) reported that prostate-specific antigen possessed proteolytic activity, but that it was not a serine protease, although the NH2-terminal sequence was very similar to serine proteases, particularly to rat submaxillary tonin (19 The reported NH2-terminal sequence for prostate-specific antigen (1 1), consisting of 68 amino acids, is to 37% identical to porcine trypsin (2 1), but the identity to both porcine pancreatic kallikrein (22) and to rat tonin (19) is 54%. These sequence homologies strongly suggest that our 33-kD prostatic serine protease (prostate-specific antigen), is more similar to the family of glandular kallikreins than to trypsin. The predominant canine prostatic enzyme is a serine protease that, because of partial sequence analysis, has also been suggested as a possible member of the glandular kallikrein family (10) . This canine enzyme has similar specificities for synthetic substrates as compared with our human protease (8) . The canine protease is reasonably the species analogue to our purified protein, as their masses and NH2-terminal sequences are very similar (10, 11) .
The NH2-terminal portion of the predominant 5.8-kD cleavage product of the HMW-SV-protein has sequence homologies with two portions ofthe histidine-rich region ofbovine high molecular weight kininogen (4 
